HBVAXPRO 10, Injektionssuspension

7680006630017 CH-663 Injektionssuspension
HBVAXPRO 10, Injektionssuspension
HBVAXPRO 10, Injektionssuspension
HBVAXPRO 10, Injektionssuspension
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
0.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.5 MG Substance HBESI

Reimbursement information

Public price
CHF 43.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2007

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
663
Drug name
HBVAXPRO 10, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BC01
Authorization status
Z
Dispensing category
B
First authorization
20/08/2002
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Hepatitis B, ab dem vollendeten 10. Lebensjahr

Package details

Description (FR)
HBVAXPRO susp inj 10 µg 1x1ml pce
Description (DE)
HBVAXPRO Inj Susp 10 µg 1x1ml Stk
Market launch
20/08/2002
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (2)

None
1 x 1 ml DUR
GTIN: None
Not in V1
HBVAXPRO susp inj 10 µg 10x1ml pce
10 x 1 ml FESP
GTIN: 7680006630123
View